Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030132 | 13,16-docosadienoic acid | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 3.86 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 3.81 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 2.59 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 2.12 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 2.77 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 4.59 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 3.19 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 4.82 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | C | 0.0 | BCD100427B001 | 2.44 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | C | 0.5 | BCD100427B003 | 4.14 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | C | 1.0 | BCD100427B007 | 2.2 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | C | 2.0 | BCD100427B011 | 1.95 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | C | 4.0 | BCD100427B015 | 2.69 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | C | 8.0 | BCD100427B019 | 4.05 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | C | 12.0 | BCD100427B023 | 4.16 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | C | 24.0 | BCD100427B027 | 4.12 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 3.06 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 3.43 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 3.77 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 3.49 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | - | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 4.22 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 6.18 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol | 0.5 | BCD100427B004 | 3.02 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol | 1.0 | BCD100427B008 | 2.28 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol | 2.0 | BCD100427B012 | 1.83 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol | 4.0 | BCD100427B016 | 3.46 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol | 8.0 | BCD100427B020 | 3.82 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol | 12.0 | BCD100427B024 | 3.32 | pmol/sample |
| LMFA01030132 | 13,16-docosadienoic acid | 25OH-Chol | 24.0 | BCD100427B028 | 3.76 | pmol/sample |